INS and type 1 diabetes mellitus: The ideal point in time for testing a possible role of vitamin D and ω-3 should be at clinical onset of T1D when, after the start of insulin therapy and the achievement of stable metabolic compensation, about 80% of children and adolescents experience a partial remission, reducing insulin demands to maintain euglycemia.